StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Pfizer (PFE) Tops Q2 EPS by 5c, Revenues Miss; Lowers FY19 EPS/Revenue Guidance
July 29, 2019 6:51 AM
(Updated - July 29, 2019 6:54 AM EDT)
Pfizer (NYSE: PFE) reported Q2 EPS of $0.80, $0.05 better than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Earnings
Guidance
Hot Corp. News
Hot Guidance
Management Comments
Next Articles
Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT
July 29, 2019 6:50 AM
Mylan (MYL) and Pfizer's (PFE) Upjohn to Combine
July 29, 2019 6:46 AM
Mylan (MYL) Mentions Potential Pfizer (PFE) Deal in Forward Looking Statement with Earnings Release
July 29, 2019 6:38 AM
Potential Mylan (MYL)/Upjohn (PFE) Merger a 'Goldilocks Scenario' - Mizuho
July 29, 2019 6:27 AM
ViiV Healthcare Reports Submission of Regulatory Application to EMA for Investigational Cabotegravir to Be Used in Combination With Rilpivirine
July 29, 2019 6:00 AM
Mylan (MYL) in Talks to Merge with Pfizer's (PFE) Off-Patent Drug Business - Reports
July 28, 2019 11:42 AM
Pfizer in talks to merge off-patent drugs business with Mylan: source
July 27, 2019 9:04 AM
Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
July 25, 2019 10:35 AM
